281 related articles for article (PubMed ID: 22262311)
1. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
[TBL] [Abstract][Full Text] [Related]
2. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
[TBL] [Abstract][Full Text] [Related]
4. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
6. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
7. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
[TBL] [Abstract][Full Text] [Related]
10. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
[TBL] [Abstract][Full Text] [Related]
11. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
13. Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma.
Cheng MF; Huang MS; Lin CS; Lin LH; Lee HS; Jiang JC; Hsia KT
Histopathology; 2014 Jul; 65(1):24-34. PubMed ID: 24382204
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
15. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma.
Ishikawa T; Nakashiro K; Hara S; Klosek SK; Li C; Shintani S; Hamakawa H
Int J Oncol; 2006 Jan; 28(1):61-6. PubMed ID: 16327980
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases.
Takayama S; Hatori M; Kurihara Y; Kinugasa Y; Shirota T; Shintani S
Oncol Rep; 2009 Jan; 21(1):205-10. PubMed ID: 19082463
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
19. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.
Lai KC; Liu CJ; Chang KW; Lee TC
Oncogene; 2013 Aug; 32(32):3686-97. PubMed ID: 22986528
[TBL] [Abstract][Full Text] [Related]
20. The role of hepatocyte growth factor activator inhibitor-1 (HAI-1) as a prognostic indicator in cervical cancer.
Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
Int J Oncol; 2009 Aug; 35(2):239-48. PubMed ID: 19578736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]